Intellectual Property India Publishes Patent Application for Methods And Compositions Comprising Lonigutamab For Treating Ted

MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202647123515 A) filed by Acelyrin, Inc. on October 15, 2026, for Methods And Compositions Comprising Lonigutamab For Treating Ted.

Inventors include Grover, Anita; Mpofu, Shephard; Nguyen, Anh; Nyborg, Andrew, C.; and Wani, Amit S..

The application for the patent was published on October 23, 2026, under issue no. 43/2026.

Abstract: The present disclosure is generally directed to pharmaceutical compositions comprising lonigutamab and methods of making and using such compositions for the treatment of thyroid eye disease (TED).

Disclaimer: Curated by HT Syndication....